Apyx Medical Corp APYX
Medical/Dental Instruments · data as of November 13, 2026
Apyx Medical Corp (APYX) is a healthcare company listed in the US with a market value of about $118M. In the twelve months to September 30, 2026 it had revenue of $60M and net income of -$8M, a net margin of -14.2%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 14% a year, a 5-year average ROIC of -25%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 81% below the current price.
About Apyx Medical
Apyx Medical is listed in the US and classified in medical/dental instruments. Revenue went from $9M in 2016 to $53M in 2025, growth of about 22.0% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 19% over three years (dilution for shareholders). It spends 6% of revenue on research and development.
Score: 0.8 / 5
Checks passed
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $60M | $53M | $48M | $52M | $45M | $49M | $28M | $28M | — | $10M | $9M |
| Net income | -$8M | -$11M | -$23M | -$19M | -$23M | -$15M | -$12M | -$20M | $63M | -$5M | -$12M |
| Free cash flow | -$9M | -$9M | -$19M | -$6M | -$21M | -$11M | -$17M | -$20M | -$21M | -$4M | -$3M |
| EPS (diluted) | $-0.19 | $-0.27 | $-0.66 | $-0.54 | $-0.67 | $-0.44 | $-0.35 | $-0.58 | $1.83 | $-0.17 | $-0.15 |
| Net margin | -14.2% | -21.2% | -48.8% | -35.8% | -52.1% | -31.3% | -42.9% | -69.8% | — | -49.5% | -131.0% |
| ROIC | — | -9.0% | -26.3% | -22.0% | -48.6% | -21.2% | -19.3% | -28.9% | -12.0% | -55.5% | -30.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Apyx Medical stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 81% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Apyx Medical pay a dividend?
Not currently.
Is Apyx Medical a good stock to buy?
We do not give buy or sell advice. Apyx Medical scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.